Anti-OCIAD2 Antilichaam

OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. OCIAD2 mRNA was found to be expressed at higher levels in invasive adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component (BAC) of the lung. Loss of OCIAD2 expression was significantly correlated with lymphatic invasion, blood vessel invasion, and lymph node metastasis, indicating that OCIAD2 may play a role in cell adhesion and prevention of cell migration. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.

Boster Bio Anti-OCIAD2 Antibody (Catalog # A13969) . Tested in ELISA, WB, IF applications. This antibody reacts with Human.

OCIA domain-containing protein 2, Ovarian carcinoma immunoreactive antigen-like protein

OCIAD2

Q56VL3

Human

OCIAD2 antibody was raised against an 18 amino acid synthetic peptide from near the carboxy terminus of human OCIAD2. The immunogen is located within the last 50 amino acids of OCIAD2.

ELISA, WB, IF

Cancer

OCIAD2 Antibody is affinity chromatography purified via peptide column.

1 mg/mL

Liquid

OCIAD2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. Avoid repeated freeze-thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

https://www.bosterbio.com/msds?sku=A13969

16954 MW

OCIA domain containing 2

Endosome .

Mouse, Bovine

OCIA domain containing 2

IgG

OCIAD2 Antibody is supplied in PBS containing 0.02% sodium azide.